Evaluation of the anticancer activity of dipyridamole and Imatinib mesylate compounds against breast cancer cell line and related biochemical and genetic changes - Egyptian Knowledge Bank - troweb

209054

Evaluation of the anticancer activity of dipyridamole and Imatinib mesylate compounds against breast cancer cell line and related biochemical and genetic changes

Article

Last updated: 04 Jan 2025

Overview Similar Items

Article

Gene Expression Analysis and Anti-cancer Activity of Cyclophosphamide for MCF-7 and H9 Cancer Cell Lines

Article

Assessment of the anticancer activity of Caryophyllene oxide against breast cancer cell line and related genetic alterations: In vitro study

Article

EVALUATION OF NEW ANTI-NEOPLASTIC ACTIVE INGREDIENT IN VITRO

Article

EXPERIMENTAL EVALUATION OF DOXORUBICIN DRUG AS ANTICANCER AGENT USING A NATURAL COMPONENT: AN IN VIRTO STUDY

Article

Evaluation of the anticancer activity of monoamidinic arylthiophenes

Article

In vitro assessment of cytotoxic and genotoxic activities of the anticancer drug doxorubicin

Article

Synthesis and Evaluation of the Antiproliferative Potency and Induced Biochemical Parameters of Novel Pyrazolones Derivatives Towards Hepatocellular Carcinoma

Article

Design, synthesis and antiproliferative evaluation of novel pyrazolo-pyrimidine derivatives with expected cyclin-dependent kinase 2 inhibitory effect

Article

ANTITUMOR ACTIVITY OF SOME NEW 1,3,8TRISUBSTITUTED PURINE-2,6-DIONES AND 1,3,6TRISUBSTITUTED THIAZOLO[2,3-f]PURINE-2,4DIONES

Article

Antioxidant and Cytotoxicity Potential of Piperine and Sorafenib combination in human MDA-MB-231 Breast Cancer cells